CClinicalTrials.gg
Not yet recruitingNCT07866690Updated Oct 8, 2026

Pain Neuroscience Education and Neuromuscular Exercise in Individuals With Chronic Low Back Pain and Central Sensitization

An interventional study of Pain Neuroscience Education and Neuromuscular Exercise in Low Back Pain, Chronic Low Back Pain and Central Sensitization, sponsored by Izmir Katip Celebi University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Izmir Katip Celebi University · Not applicable, Interventional, and Treatment

Updated Oct 8, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The goal of this randomized controlled study is to evaluate the effectiveness of pain neuroscience education (PNE) combined with neuromuscular exercises (NME) in individuals with chronic low back pain and central sensitization, and to compare the effects of this combined intervention with NME alone.

The main questions it aims to answer are:

  • Does PNE combined with NME (PNE+NME) affect pain and functional outcomes in individuals with chronic low back pain and central sensitization?
  • Does NME alone affect pain and functional outcomes in individuals with chronic low back pain and central sensitization?
  • Does adding PNE to NME affect pain and functional outcomes compared with NME alone?

Researchers will evaluate changes in pain and functional outcomes from baseline to post-intervention in both the PNE+NME and NME groups. Changes in outcomes will then be compared between the two groups to determine whether adding PNE to NME affects pain and functional outcomes compared with NME alone.

Participants will:

  • Be randomly assigned to either the PNE+NME group or the NME group.
  • Participate in the assigned intervention for 8 weeks, with 2 sessions per week.
  • Complete outcome assessments at baseline and after the 8-week intervention.
Read the detailed description

Chronic low back pain (CLBP) is a common musculoskeletal condition that can lead to persistent pain, poor functional and psychosocial outcomes. Central sensitization (CS) is present in a subgroup of individuals with CLBP and may contribute to poorer outcomes and greater clinical complexity.

Pain neuroscience education (PNE) aims to improve individuals' understanding of pain mechanisms and modify maladaptive pain-related beliefs. Neuromuscular exercises (NME) aim to improve motor control, muscle function, balance, coordination, and physical function.

This study will investigate the effectiveness of pain neuroscience education (PNE) combined with neuromuscular exercises (NME) in individuals with chronic low back pain and central sensitization and compare the effects of this combined intervention with NME alone.

After eligibility is confirmed and written informed consent is obtained, participants will be randomly assigned to either the NME group or the PNE+NME group. Both groups will participate in an 8-week exercise program with two sessions per week. The PNE+NME group will receive PNE in addition to NME.

At baseline, sociodemographic characteristics, including age, sex, height, weight, body mass index, occupation, medical history, and family history, and health-related habits, including smoking, alcohol consumption, and exercise habits, will be recorded.

The following outcomes will be assessed at baseline and after the 8-week intervention: central sensitization using the Central Sensitization Inventory; pain intensity using the Visual Analog Scale; pressure pain threshold using a pressure algometer; conditioned pain modulation; temporal summation; pain neuroscience knowledge using the Pain Neurophysiology Questionnaire; kinesiophobia using the Tampa Scale for Kinesiophobia; pain catastrophizing using the Pain Catastrophizing Scale; patient-reported physical function using the Oswestry Disability Index; performance-based physical function using the 30-Second Sit-to-Stand Test; body awareness using the Fremantle Back Awareness Questionnaire; spinal structure and mobility using the Hocoma-Valedo®Shape; trunk muscle endurance using the McGill protocol; balance using the ProKin 252 (Tecnobody); and sleep quality using the Single-Item Sleep Quality Scale.

02

Conditions studied

  • Low Back Pain
  • Chronic Low Back Pain
  • Central Sensitization

Browse trials for

Keywords

  • pain neuroscience education
  • neuromuscular exercise
03

In context

Low Back Pain

2,818 studies on the registry are indexed under Low Back Pain; 482 are open to participants now.

This study's planned enrollment of 66 is close to the median of 60 across 2,268 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Izmir Katip Celebi University is the lead sponsor of 192 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18-60 years
  • Low back pain lasting for at least 3 months
  • Low back pain as the primary complaint
  • Central Sensitization Inventory (CSI) score ≥28
  • Ability to read and write in Turkish
  • Willingness to participate in the study

Exclusion criteria

Exclusion Criteria:

  • History of spinal surgery
  • Presence of serious comorbidities (neurological, neuromuscular, cardiovascular, psychiatric conditions)
  • Presence of tumoral conditions
  • Presence of vestibular system disorders
  • Pregnancy
  • Having received physiotherapy within the previous 6 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    PNE+NME

    Participants will receive pain neuroscience education (PNE) and neuromuscular exercise (NME).

    Behavioral: Pain Neuroscience Education · Behavioral: Neuromuscular Exercise

  • Active comparator
    NME

    Participants will receive neuromuscular exercise (NME).

    Behavioral: Neuromuscular Exercise

Interventions

  • BehavioralPain Neuroscience Education

    Participants will receive pain neuroscience education (PNE) and neuromuscular exercise (NME) twice weekly for 8 weeks. Each session will last approximately 30-40 minutes.

  • BehavioralNeuromuscular Exercise

    Participants will receive neuromuscular exercise (NME) twice weekly for 8 weeks. Each session will last approximately 30-40 minutes.

06

What researchers measure

Primary outcomes

  1. Pain intensity

    Visual Analog Scale (VAS)

    Time frame: At baseline and after the 8-week intervention

Secondary outcomes

  1. Central sensitization

    Central Sensitization Inventory (CSI)

    Time frame: At baseline and after the 8-week intervention

  2. Pressure pain threshold

    Pressure algometer

    Time frame: At baseline and after the 8-week intervention

  3. Conditioned pain modulation

    Conditioned pain modulation will be assessed using pressure pain thresholds before and after ischemic conditioning with an upper-arm cuff.

    Time frame: At baseline and after the 8-week intervention

  4. Temporal summation

    Temporal summation will be assessed using repeated pressure stimuli delivered with a pressure algometer. Pain intensity after the first and tenth stimuli will be recorded using the Visual Analog Scale (VAS).

    Time frame: At baseline and after the 8-week intervention

  5. Pain neuroscience knowledge

    Revised Neurophysiology of Pain Questionnaire (RNPQ)

    Time frame: At baseline and after the 8-week intervention

  6. Kinesiophobia

    Tampa Scale for Kinesiophobia (TSK)

    Time frame: At baseline and after the 8-week intervention

  7. Pain catastrophizing

    Pain Catastrophizing Scale (PCS)

    Time frame: At baseline and after the 8-week intervention

  8. Body awareness

    Fremantle Back Awareness Questionnaire (FreBAQ)

    Time frame: At baseline and after the 8-week intervention

  9. Disability

    Oswestry Disability Index (ODI)

    Time frame: At baseline and after the 8-week intervention

  10. Performance-based physical function

    30-Second Sit-to-Stand Test (30 s- STS)

    Time frame: At baseline and after the 8-week intervention

  11. Spinal structure and mobility

    Hocoma-Valedo®Shape

    Time frame: At baseline and after the 8-week intervention

  12. Trunk muscle endurance

    McGill trunk endurance test

    Time frame: At baseline and after the 8-week intervention

  13. Balance

    ProKin 252 (Tecnobody)

    Time frame: At baseline and after the 8-week intervention

  14. Sleep quality

    Single-Item Sleep Quality Scale

    Time frame: At baseline and after the 8-week intervention

07

Study locations

1 site
  • Izmir Katip Celebi University
    Izmir, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07866690
Lead sponsor
Izmir Katip Celebi University
Responsible party
Sevinc Akdeniz (PT, MSc, Izmir Katip Celebi University) — Principal investigator
First posted
Oct 8, 2026
Start date
Oct 2026 (estimated)
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Oct 8, 2026

Study contacts

Sevinc Akdeniz, MSc
Contact
sevinc.akdeniiz@gmail.com
+90 535 077 53 46
Derya Ozer Kaya, PhD, Prof.
study director · Izmir Katip Celebi University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion